Cited by

• Novel therapy for the treatment of human carcinoid.

  Evers BM, Hurlbut SC, Tyring SK, Townsend CM Jr, Uchida T, Thompson JC. Evers BM, et al. Ann Surg. 1991 May;213(5):411-6. doi: 10.1097/00000658-199105000-00005. Ann Surg. 1991. PMID: 1708983 Free PMC article.
• Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes.

  Grama D, Eriksson B, Mårtensson H, Cedermark B, Ahrén B, Kristoffersson A, Rastad J, Oberg K, Akerström G. Grama D, et al. World J Surg. 1992 Jul-Aug;16(4):632-9. doi: 10.1007/BF02067341. World J Surg. 1992. PMID: 1357829
• The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review.

  Zagami P, Kandaraki E, Renne G, Grimaldi F, Spada F, Laffi A, Fazio N. Zagami P, et al. Ecancermedicalscience. 2020 Oct 15;14:1123. doi: 10.3332/ecancer.2020.1123. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33209114 Free PMC article.
• Surgical treatment of mid-gut carcinoid tumors.

  Makridis C, Oberg K, Juhlin C, Rastad J, Johansson H, Lörelius LE, Akerström G. Makridis C, et al. World J Surg. 1990 May-Jun;14(3):377-83; discussion 384-5. doi: 10.1007/BF01658532. World J Surg. 1990. PMID: 2368441
• Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm.

  Konno H, Arai T, Tanaka T, Baba M, Matsumoto K, Kanai T, Nakamura S, Baba S, Naito Y, Sugimura H, Yukita A, Asano M, Suzuki H. Konno H, et al. Jpn J Cancer Res. 1998 Sep;89(9):933-9. doi: 10.1111/j.1349-7006.1998.tb00651.x. Jpn J Cancer Res. 1998. PMID: 9818029 Free PMC article.